147 related articles for article (PubMed ID: 34847951)
1. Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model.
Hussain K; Ikram R; Ambreen G; Salat MS
J Pharm Policy Pract; 2021 Nov; 14(1):100. PubMed ID: 34847951
[TBL] [Abstract][Full Text] [Related]
2. Bridging the Gap between Theory and Practice; the Active Role of Inpatient Pharmacists in Therapeutic Drug Monitoring.
Alhameed AF; Khansa SA; Hasan H; Ismail S; Aseeri M
Pharmacy (Basel); 2019 Feb; 7(1):. PubMed ID: 30781607
[TBL] [Abstract][Full Text] [Related]
3. Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin-an epidemiological surveillance study using Japanese large health insurance claims database.
Imai S; Momo K; Kashiwagi H; Miyai T; Sugawara M; Takekuma Y
J Pharm Health Care Sci; 2020; 6():18. PubMed ID: 32832095
[TBL] [Abstract][Full Text] [Related]
4. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
Xu G; Chen E; Mao E; Che Z; He J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
[TBL] [Abstract][Full Text] [Related]
5. [Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy].
Imai S; Yamada T; Ishiguro N; Miyamoto T; Kagami K; Tomiyama N; Niinuma Y; Nagasaki D; Suzuki K; Yamagami A; Kasashi K; Kobayashi M; Iseki K
Yakugaku Zasshi; 2017; 137(9):1185-1192. PubMed ID: 28867705
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement.
Olson J; Hersh AL; Sorensen J; Zobell J; Anderson C; Thorell EA
J Pediatric Infect Dis Soc; 2020 Jul; 9(3):334-341. PubMed ID: 31344233
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant
Hirano R; Sakamoto Y; Kitazawa J; Yamamoto S; Tachibana N
Infect Drug Resist; 2016; 9():243-252. PubMed ID: 27789965
[TBL] [Abstract][Full Text] [Related]
8. The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin-A Pilot Study.
Firman P; Tan KS; Clavarino A; Taing MW; Dixon S; Singh H; Whitfield K
Pharmacy (Basel); 2022 Dec; 10(6):. PubMed ID: 36548329
[TBL] [Abstract][Full Text] [Related]
9. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.
Iwamoto T; Kagawa Y; Kojima M
Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304
[TBL] [Abstract][Full Text] [Related]
11. Experience of Vancomycin Therapeutic Drug Monitoring in Two Multidisciplinary Hospitals in Latvia.
Mauliņa I; Darbiniece K; Miķelsone-Jansone L; Erts R; Bandere D; Krūmiņa A
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334546
[TBL] [Abstract][Full Text] [Related]
12. A New Algorithm Optimized for Initial Dose Settings of Vancomycin Using Machine Learning.
Imai S; Takekuma Y; Miyai T; Sugawara M
Biol Pharm Bull; 2020; 43(1):188-193. PubMed ID: 31902925
[TBL] [Abstract][Full Text] [Related]
13. Influence of cerebrospinal fluid drainage and other variables on the plasma vancomycin trough levels in postoperative neurosurgical patients.
Chen C; Xu P; Xu T; Zhou K; Zhu S
Br J Neurosurg; 2021 Apr; 35(2):133-138. PubMed ID: 32456472
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.
Komoto A; Maiguma T; Teshima D; Sugiyama T; Haruki Y
PLoS One; 2018; 13(9):e0203453. PubMed ID: 30188918
[TBL] [Abstract][Full Text] [Related]
15. The impact of an electronic hospital system on therapeutic drug monitoring.
Firman P; Whitfield K; Tan KS; Clavarino A; Hay K
J Clin Pharm Ther; 2021 Dec; 46(6):1613-1621. PubMed ID: 34328229
[TBL] [Abstract][Full Text] [Related]
16. Pharmacist-Managed Therapeutic Drug Monitoring Programs within Australian Hospital and Health Services-A National Survey of Current Practice.
Firman P; Tan KS; Clavarino A; Taing MW; Whitfield K
Pharmacy (Basel); 2022 Oct; 10(5):. PubMed ID: 36287457
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the appropriateness of vancomycin therapeutic drug monitoring in the intensive care unit with a clinical pharmacy approach, a cross-sectional study.
Dinçel S; Demirpolat E
Eur J Hosp Pharm; 2024 Jun; ():. PubMed ID: 38834285
[TBL] [Abstract][Full Text] [Related]
18. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
[TBL] [Abstract][Full Text] [Related]
19. Impact of vancomycin therapeutic drug monitoring on patient care.
Welty TE; Copa AK
Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
